Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ARD-101 / Aardvark Therap
HERO, NCT06828861: ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial	Recruiting	3	90	Europe, Canada, US, RoW	Placebo, ARD-101	Aardvark Therapeutics, Inc.	Hyperphagia, Prader-Willi Syndrome	03/26	04/26
NCT05215847: Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery	Completed	2	12	US	ARD-101	Aardvark Therapeutics, Inc., University of California, San Diego	Bariatric Surgery, Obesity, Weight Gain	02/23	02/23
NCT05153434: A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome	Active, not recruiting	2	18	US	ARD-101	Aardvark Therapeutics, Inc., Children's Hospital Colorado, Stanford University	Prader-Willi Syndrome	11/24	02/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ARD-101 / Aardvark Therap
HERO, NCT06828861: ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial	Recruiting	3	90	Europe, Canada, US, RoW	Placebo, ARD-101	Aardvark Therapeutics, Inc.	Hyperphagia, Prader-Willi Syndrome	03/26	04/26
NCT05215847: Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery	Completed	2	12	US	ARD-101	Aardvark Therapeutics, Inc., University of California, San Diego	Bariatric Surgery, Obesity, Weight Gain	02/23	02/23
NCT05153434: A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome	Active, not recruiting	2	18	US	ARD-101	Aardvark Therapeutics, Inc., Children's Hospital Colorado, Stanford University	Prader-Willi Syndrome	11/24	02/25